Piper Sandler cuts TriCo Bancshares stock rating on acquisition

Piper Sandler downgraded TriCo Bancshares to Neutral, lowering its price target to $61 from $63 (stock at ~$60.07, ~28.7% YTD). The downgrade follows First Hawaiian’s planned all-stock acquisition of TriCo using an exchange ratio of 2.095x, with TriCo shareholders receiving 2.095 First Hawaiian shares per TriCo share (~$63.12 value). Piper raised FHB’s 2026/2027 EPS to $2.38/$2.42 and projects the deal will be ~6% accretive on a fully phased-in basis, while TriCo continues paying dividends (2.4% yield cited).

Analysis

This is more of a merger-arb setup than a clean fundamental long. The target should increasingly trade as a function of the acquirer’s stock, not its own standalone earnings, so the key variable is not the headline premium but whether the buyer’s currency holds up into approval. For the acquirer, the market will care less about modeled accretion and more about whether it can issue stock above tangible book without compressing the combined multiple; if the stock weakens, the deal becomes value-destructive on a relative basis even if EPS accretion remains positive on paper.

The second-order winner is the regional-bank M&A complex: a completed stock deal that is modestly accretive and administratively simple can reopen the bid for other subscale lenders with clean balance sheets. That favors high-capital, deposit-stable names in the same broad cohort, while banks with weaker currencies or messy credit narratives could see their own takeout optionality discounted. The loser is anyone long the target expecting a static premium—its valuation now has equity-market beta to the buyer until closing.

Near term, the spread should be driven by deal mechanics and the acquirer’s tape over the next 1-3 months, not by operating fundamentals. The main falsifiers are a meaningful drop in the buyer’s shares, slower-than-expected regulatory progress, or any sign that the accretion assumptions depend on too-optimistic funding-cost normalization. Longer term, if the transaction closes and integration remains clean, the market may reward the buyer with a modest re-rating for disciplined consolidation, but that is a 6-18 month story, not a trading catalyst today.

Key Decisions for Investors

• Long TCBK / short FHB in deal ratio size as a classic stock-for-stock arb for the next 4-12 weeks; target is the closing spread, with the main risk being FHB underperformance or a regulatory delay.
• If the spread is already tighter than low-single-digit percent gross, avoid fresh entry and wait for a post-announcement pullback in either name; the edge here is timing, not conviction.
• Watch KRE and regional-bank peer multiples for confirmation: if the basket firms while FHB holds up, consider adding to the arb; if KRE rolls over, reduce quickly because the target’s implied value will follow the buyer lower.
• For directional exposure, prefer a small long FHB only on weakness below the deal-implied value with a tight stop on any 5-7% relative underperformance versus TCBK; otherwise the stock is likely capped by merger math.
• Set an alert for regulatory filing milestones and first post-deal-quarter guidance; any slippage there would widen the spread and invalidate the near-term arb case.